Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Millennium licenses chronic asthma treatment to Taisho

Jan. 11, 2000

New series of NK2 receptor antagonists developed at Pfizer

Jan. 10, 2000

Zambon and Sheffield begin clinical program for MSI-ipratropium

Jan. 6, 2000

New nonpeptide compound AY-0068 is a potent, selective and metabolically stable tryptase inhibitor

Jan. 4, 2000

Inspire and UNC describe method of enhancing airways mucus secretion

Jan. 4, 2000

Avanir's new benzimidazole analogues inhibit IgE response to allergens

Jan. 4, 2000

Preclinical pharmacokinetics of SB-240563 support clinical development for asthma

Jan. 3, 2000

CFC-free flunisolide to be developed by 3M/Forest partnership

Jan. 3, 2000

Specific VLA-4 inhibitor designed at Biogen for cell adhesion-mediated pathologies

Jan. 3, 2000

FDA approves new treatment for respiratory failure in neonates

Dec. 30, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...